When a company faces mounting public scrutiny, especially in high-stakes litigation, it sometimes does what any crisis playbook might suggest: change the name. It’s not a financial reset. It’s a ...
A district judge has ruled that physicians can move forward with a federal lawsuit that accuses insurers and an analytics company of underpaying them by billions through a price-fixing scheme for ...
A federal judge dismissed an antitrust lawsuit from Rocky Point, N.Y.-based Long Island Anesthesiologists who alleged that UnitedHealthcare and MultiPlan conspired to slash reimbursement rates by more ...
Multiplan Real Estate Asset Management landed a $30 million construction loan for its planned oceanfront condos in Surfside. Records show Coral Gables-based Bradesco Bank is supplying the financing ...
MultiPlan, a data technology company that works primarily with payers, has announced refinancing to extend the maturities of its entire debt capital structure. MultiPlan said it has entered into an ...
On Wednesday, Piper Sandler adjusted its outlook on Multiplan Co. (NYSE: MPLN), reducing the price target significantly to $10 from the previous $40 while maintaining a Neutral rating on the stock.
Cost management company MultiPlan is facing yet another lawsuit for allegedly conspiring to underpay providers — this time, from the largest physician association in the United States. The American ...
Tara O’Neil Promoted to General Counsel; Scott Mays Promoted to SVP, Legal and Deputy General Counsel Tara O’ Neil has been promoted to General Counsel from her former role as the Senior Vice ...
MultiPlan Corporation (MPLN) shares rallied 9% in the last trading session to close at $7.87. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Lawmakers are zeroing in on MultiPlan, a firm that has helped insurers cut payments while sometimes leaving patients with large bills. By Chris Hamby Chris Hamby has been investigating the lucrative ...
MultiPlan has helped big health insurers make billions by reducing reimbursements for medical bills, but its business model is now being questioned. By Chris Hamby Chris Hamby has been investigating ...